A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...

Izuchukwu Okpalanwaka is a pharmacist and a doctoral researcher at the Texas Tech University Health Science Center (TTUHSC), United States. He is also the co-founder of the Tropical Medical Oncology ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

A clinical trial suggests Lenacapavir, a yearly injection, could revolutionise HIV prevention by offering long-term ...

During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...

AIDS advocates are fearful that budget cuts being pushed by Republicans will gut essential health care services in the United ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

HIV is not like TB. While TB treatment takes six long months, this is a curable disease. HIV, on the other hand, cannot be ...

At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full day of the conference, reports from the ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...